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INTRODUCTION
Stroke is the dangerous disease accounting for the leading cause 
of death or disorder worldwide. While stroke has a high mortality 
rate and causes serious suffer after recovery, there is no complete 
therapy. In ischemic stroke, inflammatory cells such as macrophage 
and monocyte move into the lesion area [1, 2]. Furthermore, 
microglia can quickly undergo morphologic transformation 
from a resting condition to an activating condition, where they 
become virtually indistinguishable from circulating macrophages 
[3, 4]. Activated microglia have been shown to release a variety 
of cytokines contributing to cell damage or cell repair leading to 
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Original Article
Microglia play a key role in the immune response and inflammatory reaction that occurs in response to ischemic stroke. Activated 
microglia promote neuronal damage or protection in injured brain tissue. Extracellular signals polarize the microglia towards the 
M1/M2 phenotype. The M1/M2 phenotype microglia released pro- and anti-inflammatory cytokines which induce the activation of 
neural stem/progenitor cells (NSPCs). In this study, we investigated how the cytokines released by microglia affect the activation of 
NSPCs. First, we treated BV2 cells with a lipopolysaccharide (LPS; 20 ng/ml) for M1 phenotype microglia and interleukin-4 (IL-4; 20 
ng/ml) for M2 phenotype microglia in BV2 cells. Mice were subjected to transient middle cerebral artery occlusion (tMCAO) for 1 h. 
In ex vivo, brain sections containing the subventricular zone (SVZ) were cultured in conditioned media of M1 and M2 phenotype-
conditioned media for 3 d. We measured the expression of cytokines in the conditioned media by RT-PCR and ELISA. The M2 
phenotype microglia-conditioned media led to the proliferation and neural differentiation of NSPCs in the ipsilateral SVZ after 
ischemic stroke. The RT-PCR and ELISA results showed that the expression of TGF-α mRNA was significantly higher in the M2 
phenotype microglia-conditioned media. These data support that M2 phenotype microglia-derived TGF-α is one of the key factors 
to enhance proliferation and neural differntiation of NSPCs after ischemic stroke.
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exacerbated brain injury [5]. In ischemic stroke, resting microglia 
can be polarized to the M1 phenotype, or alternatively to pro-
phagocytic M2 phenotype through different signals [6-8]. The 
M1 phenotype promotes the transcriptional activation of nuclear 
factor-kB (NF-kB) and generates high levels of pro-inflammatory 
cytokines and oxidative metabolites [9]. In contrast, the M2 
phenotype is triggered by anti-inflammatory cytokines [10, 11], 
which are thought to inhibit inflammation and enhance tissue 
repair and wound healing [12].
In ischemic stroke, the progenitor cells in SVZ become into a 
new neural cell that could be one of the therapies to neurogenesis 
[13]. Following focal ischemia, enhanced neurogenesis including 
an increased proliferation of neural progenitors in the ipsilateral 
SVZ, migration of neuroblasts from the SVZ to the injured 
striatum, and functional differentiation and integration of newly 
generated cells in the damaged brain has been observed in many 
studies [14]. Activated microglia accumulate in postnatal SVZ 
and induce neurogenesis and oligodendrogenesis via released 
cytokines [15]. We and others have investigated how microglia 
affect the activation of progenitor cells in the SVZ after ischemic 
stroke. This is still unclear and controversial.
Therefore, the objective of this study is to explore further 
the effect of  microglia-derived cytokine on the process of 
proliferation, neurogenesis and neural differentiation of NSPCs in 
SVZ after ischemic stroke.
MATERIALS AND METHODS
BV2 cell culture
Murine BV2 cell line, which was originally immortalized 
after infection with a v-raf/v-myc recombinant retrovirus [16], 
and maintained at 37oC at 5% CO2 at Roswell Park Memorial 
Institute (RPMI)-1640 (Thermo Scientific) with 10% fetal bovine 
serum (FBS; Thermo Scientific) and 1% penicillin/streptomycin 
(Thermo Scientific). To polarize the M1 phenotype activated by 
LPS or M2 phenotype activated by IL-4, BV2 cells were treated 
with LPS (20 ng/ml, Sigma-Aldrich) and IL-4(20 ng/ml, cell 
signaling), respectively. Cultured media containing the BV2 cells 
were transferred to serum-free RPMI-1640 media after 24 h 
stimulation and cultured further for 48 h. The serum-free RPMI-
1640 conditioned media was collected with a 0.22 μm filter and 
stored at -70oC until use [13]. To determine the role of TGF-α in 
M2 conditioned media, TGF-α antibody (0.2 ng/ml) was added to 
the M2 conditioned media for TGF-α neutralization. The control 
media used serum-free RPMI-1640 media.
Experimental animals
Adult male ICR mice (8 weeks old, Coatech) were used in this 
study and kept under a 12 h light/dark cycle with freely accessible 
food and water. All animal experiments were approved by the 
Committee for the Care and Use of Laboratory Animals at 
Yonsei University Health System (2011-0212) and performed in 
accordance with the National Institute of Health guidelines for the 
Care and Use of Laboratory Animals.
Transient middle cerebral artery occlusion
Three days prior to tMCAO, all experimental animals were 
labeled with 5-bromo-2’-deoxyuridine (BrdU; 50 mg/kg, daily 
intraperitoneal (IP) injection, Sigma-Aldrich). Before the 
surgery, animals were anesthetized with Zoletil50® (30 mg/kg) 
and Rompun (10 mg/kg). Body temperature was maintained 
37.5oC with a heating pad. Ischemic stroke was induced using an 
intraluminal stature as described earlier [17]. In brief, an uncoated 
15 mm segment of 6-0 nylon mono filament suture with the 
tip rounded by a flame was inserted into the internal carotid 
artery via common carotid artery until the suture occluded the 
middle cerebral artery. After 60 min occlusion, the suture was 
removed and surgical incisions were closed. Animals were kept 
on the heating pad before awakening. Food and water were freely 
accessible in their cages.
Immunocytochemistry
The characteristics of the BV2 cells after LPS or IL-4 induced 
stimulation were confirmed by immunocytochemistry. Samples 
were fixed with 4% paraformaldehyde, permeabilized with PBS 
in 0.025% Triton X-100 and blocked with goat serum at room 
temperature (RT). Primary antibodies as anti-rabbit CD68 
(1:200, Santa Cruz) and anti-goat CD206 (1:200, Santa Cruz) 
were incubated for 3 h at RT. Samples were washed with PBS. The 
samples were incubated with Alexa-488 donkey anti-rabbit and 
Alexa-594 donkey anti-goat (1:200, Santa Cruz) for 1 h at RT. The 
samples were washed with PBS and counterstained with 1 μg/ml 
4’,6-diamidino-2-phenylindole (DAPI; 1:500, Invitrogen) for 1 
min at RT.
Organotypic cultures of nervous tissue
Organotypic culture was prepared according to a previously 
decribed method [18]. After 6 h reperfusion, Mice were 
decapitated atfer 6 h reperfusion. The extracted brain samples 
were embedded in 5% low melting agarose gel and hardened at RT. 
The embedded brains were serially cut in the coronal plane into 
200 μm thick sectins using a vibratome. The sectioned brains were 
transiently stored in artificial cerebrospinal fluid (ACSF; 119 mM 
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NaCl, 26.2 mM NaHCO3, 2.5 mM KCl, 1 mM NaH2PO4, 1.3 mM 
MgCl2, 10 mM glucose, and 2.5 mM CaCl2). ACSF was sterilized 
with a 0.22 μm filter apparatus and oxygenated with 95% O2 and 
5% CO2 for 10~15 min before use. The sliced brains with SVZ 
region were placed on a cell culture insert with 0.4 μm pore size 
(FALCON) in 6-well plates. The cell culture inserts were filled with 
2 ml conditioned media (M0, M1, and M2 phenotypes). The sliced 
brain samples were incubated in 5% CO2 incubator at 37
oC for 72 h.
Immunohistochemistry
All samples were fixed with 4% paraformaldehyde for 1 h and 
then washed with PBS with 1% Tween-20. For BrdU staining, the 
sliced brains were rinsed in PBS, denatured in 4 N HCl at RT for 
30 min, and neutralized in 0.1 M boric acid for 10 min. Samples 
were rinsed and blocked with PBS include 10% FBS and 1% Tween 
20. Primary antibodies of anti-rabbit Ki67 (1:500, Abcam), anti-
mouse BrdU (1:200, Thermo Scientific), anti-rabbit DCX (1:200, 
Abcam), anti-rabbit NeuN (1:200, Abcam), and anti-rabbit Olig2 
(1:200, Abcam) were added to the samples and incubated for 48 h 
at 4oC. Samples were washed with PBS with 1% Tween 2, followed 
by incubation with Alexa-594 donkey anti-rabbit and Alexa-488 
donkey anti-mouse (1:200, Santa Cruz) at RT for 1 h. Samples 
were washed with PBS and stained with 1 μg/ml 4’,6-diamidino-2- 
phenylindole (DAPI; 1:500, Invitrogen) for 3 min at RT. The 
stained brain samples were captured using LSM 700 confocal 
microscope (Carl Zeiss).
Reverse transcription polymerase chain reaction 
Total RNA was extracted from BV2 cells by TRIzol (Invitrogen) 
following the instructions protocol and the mRNA was quantified 
by spectrophotometric analysis. Total RNA (2 μg) from each 
sample was transcribed into cDNA and synthesized PCR 
amplicon using SuperScript III One-Step RT-PCR System with 
platinum® Taq DNA Polymerase (Invitrogen) according to the 
manufacturer’s instructions; The following primers were used: 
TGF-α primer pairs forward: TACCGCTGGGTATCCTGTTA 
and reverse: TTCTCATGTCTGCAGACGAG, IL-10 primer 
pairs forward: CCAAGCCTTATCGGAAATGA and reverse: 
TTTTCACAGGGGAGAATCG and GAPDH primer pairs 
for ward: TGGCACAGTCAAGGCTGAGA and re verse: 
CTTCTGAGTGGCAGTGATGG. The thermal cycling conditions 
were set to 95oC for 10 min, followed by 95oC for 15 sec, 60oC 
for 30 sec, and 68oC for 1 min, repeated 40 times. The mRNA 
expression was normalized to the levels of GAPDH.
ELISA assay
To determine the soluble TGF-α concentration in the different 
phenotypes of supernatant in BV2 cells, the conditioned media 
were measured by the mouse TGF-α ELISA Kit (E-EL-M1190, 
Elabscience) according to the manufacturer’s instructions. All steps 
were performed at 37oC. In a 96-well plate which is coated with 
the capture antibody, 100 ul of the standard solution, blank and 
samples were loaded for 90 min incubation. Absorbance was read 
at 450 nm using a microplate reader.
Statistical analysis
Statistical comparisons were made between multiple groups 
using analysis of variance (ANOVA) followed by Tukey’s Honestly 
significant difference (HSD) test. The level of significance was set 
at p≤0.05. Data were expressed as the mean±standard deviation 
(SD).
RESULTS
LPS or IL-4 induce M1/M2 type polarization of BV2 microglia 
cell
To confirm the polarization of microglia, BV2 microglia were 
Fig. 1.  Polarization of  BV2 microglial cells using conditioned 
media. (A) Schematic time course of the in vitro  experiments. (B) 
Immunohistochemistry of CD68 (M1 phenotype microglia; green) 
and CD206 (M2 phenotype microglia; red). In BV2 microglial cell, the 
expression of CD68 significantly increased in M1 conditioned media 
compared with M2 conditioned media. CD206 is expressed only in M2 
conditioned media (Scale bar=20 um, n=5/group).
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treated with the LPS (M1 phenotype) or IL-4 (M2 phenotype) 
(Fig. 1A). After 72 h incubation, these supernatants were harvested 
in the M1 conditioned media and M2 conditioned media, 
respectively, from the BV2 cell culture. Serum free RPMI 1640 
media were labeled as M0 conditioned media (M0 CM). We 
performed immunocytochemistry against CD 68 (M1 phenotype) 
and CD 206 (M2 phenotype) [19] in BV2 microglia cells polarized 
by LPS or IL-4 for 72 h (Fig. 1B). Overexpression of CD68 was 
observed in BV2 cells induced by M1 conditioned media, however, 
CD68 expression decreased in M2 conditioned media. CD206 
expression was observed only in BV2 microglia cells induced by 
M2 conditioned media. 
M2 conditioned media stimulates the cellular proliferation 
in SVZ of the organotypic brain after ischemic stroke
To investigate whether M0, M1, and M2 conditioned media 
affect cellular proliferation in SVZ of the organotypic brain after 
ischemic stroke, ex vivo  organotypic culture was performed in 
3 different conditioned media for 3 d (Fig. 2A). Ki67 expression 
increased significantly during the G1-, S-, M- and G2-phase of 
the cell cycle. BrdU incorporate into the newly synthesized DNA 
strands of S-phase cells and is useful for estimating the fraction 
of cells in S-phase. We counted the number of Ki67+ and BrdU+-
double labeled cells to confirm the cellular proliferation in SVZ 
for 7 d after ischemic stroke. Immunohistochemistry showed that 
Ki67+ and BrdU+-double labeled cells were significantly increased 
in M2 conditioned media compared with M0 and M1 conditioned 
media (Fig. 2B and 2C). These results suggest that M2 conditioned 
media strongly promoted the cellular proliferation in SVZ after 
ischemic stroke.
M2 conditioned media stimulates the neurogenesis, oligo-
dendrogenesis and neural differentiation of SVZ-NSPCs in 
the organotypic brain after ischemic stroke
To determine the characteristics of proliferating in SVZ of the 
organotypic brain after ischemic stroke, immunohistochemistry 
was performed using doublecortin (DCX), NeuN, Olig2, and 
BrdU. DCX, which is a microtubule-associated protein essential for 
the migration of neurons in the human brain, is highly expressed 
in neuronal progenitor cells or migrating neuroblasts. The results 
showed that M2 conditioned media significantly increased DCX+ 
and BrdU+ cells in SVZ compared with M0 and M1 conditioned 
media after ischemic stroke. The quantification graph shows 
significantly increased cell number in M2 conditioned media 
(Fig. 3A and 3B). Next, to determine the neural differentiation 
of SVZ-NSPCs after ischemic stroke, immunohistochemistry 
was performed using NeuN, Olig2, and BrdU were performed. 
NeuN reacts with most neuronal cells in the nervous system. The 
results showed that M2 conditioned media significantly increased 
NeuN+ and BrdU+ cells in SVZ compared with M1 conditioned 
media after ischemic stroke. The quantification graph shows 
significantly increased cell number in the M2 conditioned media 
(Fig. 3C and 3D). Olig2 is specifically expressed in nervous tissue 
as a gene regulator of oligodendrogenesis. The result showed 
Fig. 2.  Proliferation SVZ-NSPCs in 
M2 conditioned media. (A) Schematic 
time course of the in vivo  and ex vivo 
experiments. (B) Immunohistochemistry 
of Ki67 and BrdU in M0, M1, and M2 
conditioned media shows the proliferation 
of SVZ-NSPCs in THE organotypic brain. 
(C) Quantification graph of the ratio of 
Ki67+ and BrdU+ cells of SVZ-NSPCs 
in organotypic brain (Scale bar=20 um, 
**p<0.05 vs. M0 conditioned media, n=5/
group).
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that M2 conditioned media was significantly increased Olig2+ 
and BrdU+ cells in SVZ compared with M0 and M1 conditioned 
media after ischemic stroke. The quantification graph shows 
significantly increased cell number in M2 conditioned media (Fig. 
3E and 3F). Together, these results ascertain that M2 conditioned 
media promotes the neurogenesis, oligodendrocyte and neural 
differentiation of SVZ-NSPCs after ischemic stroke.
TGF-α is one of the major cytokines in M2 conditioned 
media
Using RT-PCR and ELISA, we subsequently identified a 
key cytokine in M2 conditioned media, which promoted the 
proliferation, neurogenesis and neural differentiation of SVZ-
NSPCs after ischemic stroke. The expression of IL-10 and TGF-α 
mRNA was significantly increased in M2 conditioned media 
compared with M0 and M1 conditioned media (Fig. 4A and 
4B). ELISA assay was performed to quantitate TGF-α in the M2 
conditioned media. The data showed that the level of TGF-α was 
Fig. 3. Differentiation of SVZ-NSPCs in 
M2 conditioned media. M0, M1, or M2 
conditioned media induced the differentiation 
of SVZ-NSPCs in the organotypic brain. 
(A and B) Immunohistochemistry and 
quantification graph of the ratio of DCX+ and 
BrdU+ cells of SVZ-NSPCs in the organotypic 
brain. (C and D) Immunohistochemistry and 
quantification graph of the ratio of NeuN+ and 
BrdU+ cells of SVZ-NSPCs in the organotypic 
brain. (E and F) Immunohistochemistry and 
quantification graph of the ratio of Olig2+ and 
BrdU+ cells of SVZ-NSPCs in the organotypic 
brain (Scale bar=20 um; **p<0.05, ***p<0.01 
vs. M0 conditioned media; n=5/group).
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significantly increased in M2 conditioned media compared with 
M0 and M1 conditioned media (Fig. 4C). The results indicate that 
TGF-α is one of the major cytokines in M2 conditioned media 
and may be affected in the proliferation, neurogenesis, and neural 
differentiation of SVZ-NSPCs after ischemic stroke.
TGF-α plays key role in the proliferation and neurogensis of 
SVZ-NSPCs after ischemic stroke
To investigate the role of TGF-α in the proliferation, neuro-
genesis, and neural differentiation of SVZ-NSPCs, we treated the 
SVZ-NSPCs with or without neutralizing antibody against TGF-α 
in M2 conditioned media. Immunohistochemistry analyses 
revealed that Ki67+ and BrdU+ of SVZ-NSPCs was significantly 
increased (1.6 fold) in no neutralized TGF-α in M2 conditioned 
media (Fig. 5A and 5B). Next, we assessed the neural progenitor 
cells or migrating neuroblasts of SVZ-NSPCs after ischemic 
stroke using immunohistochemistry of DCX and BrdU. This data 
showed that DCX+ and BrdU+ of SVZ-NSPCs was significantly 
increased (1.8 fold) in non-neutralizing TGF-α in M2 conditioned 
media (Fig. 5C and 5D). To determine the neuronal differentiation 
of SVZ-NSPCs after ischemic stroke, immunohistochemistry 
was performed using NeuN and BrdU. This data showed that 
the number of  NeuN+ and BrdU+ of  SVZ-NSPCs did not 
significantly change, but not change with or without neutralizing 
TGF-α in M2 conditioned media (Fig. 5E and 5F). To determine 
the oligodendrogenesis of SVZ-NSPCs after ischemic stroke, 
immunohistochemistry was conducted using Olig2 and BrdU. 
This data showed that the number of Olig2+ and BrdU+ cells 
of SVZ-NSPCs also slightly increased, but not changed with or 
without neutralizing TGF-α in M2 conditioned media (Fig. 5G 
and 5H). Therefore, these results suggest that TGF-α might play a 
key role in the proliferation and neurogenesis of SVZ-NSPCs after 
ischemic stroke, but not in neural differentiation.
DISCUSSION
Neural stem cells (NSCs) are mainly located on the subgranular 
zone of the dentate gyrus of the hippocampus and the forebrain 
SVZ in the postnatal mammalian brain [20, 21]. Numerous 
studies demonstrated that activated microglia are important in 
neurogenesis in the adult SVZ; however, microglial contribution 
to neurogenesis is complex [22, 23]. Recently, the role of microglia 
in neurogenesis has been examined mainly in pathological 
conditions [24, 25]. Microglia, which is a kind of immune cell, 
perform main function of immune response in the brain [26-28]. 
Microglia have two efficiencies which are totally different effects. 
Once activated by extracellular signals, activated microglia have 
predominantly harmful effects in the acute stages of ischemic 
stroke, and that most beneficial effects appear in delayed stages 
[29, 30]. Microglia also play diverse roles in neurogenesis in both 
the embryonic and postnatal adult stages [31]. Recently, a study 
demonstrated that microglia related to neurogenesis of embryonic 
SVZ. During the late stages of cortical neurogenesis, microglia 
regulated the size of the neuronal precursor pool through the 
phagocytosis of Tbr21 and Pax61 cells [32]. Remarkably, most 
precursor cells, which were targeted by microglia, did not undergo 
cell death. Activated microglia accumulate in the SVZ during 
the early postnatal period and then disperse to white matter 
where they became more ramified. In in vivo and in vitro studies, 
activated microglia in the early postnatal SVZ also enhanced 
neurogenesis and oligodendrogenesis via the released cytokine 
[15]. The enhancement of neurogenesis was suppressed by a 
Fig. 4. TGF-α is one of the major cytokines in M2 conditioned media. (A) RT-PCR of IL-10 and TGF-α in M0, M1, or M2 conditioned media. IL-10 
and TGF-α expression is significantly increased at the mRNA level in M2 conditioned media. (B) The graph depicts the relative mRNA expression of 
IL-10 and TGF-α in M0, M1, and M2 conditioned media. The expression of these genes is significantly increased in M2 conditioned media. (C) The 
expression level of TGF-α in M0, M1, and M2 conditioned media using ELISA assay. The quantity of TGF-α is significantly increased in M2 conditioned 
media compared with M1 (***p<0.01 vs. M0 conditioned media, n=5/group).
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combination of function-blocking antibodies to cytokines, but not 
by any single antibody in the in vitro co-culture system of NSPCs 
and microglia [15]. This variability in the effects of microglia on 
neurogenesis displayed the different polarizations of microglia 
and/or the precise status of NSCs/neuronal progenitor cells 
(NPCs) [33-35] and crosstalk between them [36]. Another study 
Fig. 5. Effect of TGF-α on the proliferation and neurogenesis of SVZ-NSPCs after cerebral ischemia. (A and B) Immunohistochemistry and 
quantification graph of the ratio of Ki67+ and BrdU+ cells of SVZ-NSPCs in the organotypic brain. (C and D) Immunohistochemistry and quantification 
graph of the ratio of DCX+ and BrdU+ cells of SVZ-NSPCs in organotypic brain. (E and F) Immunohistochemistry and quantification graph of the ratio 
of NeuN+ and BrdU+ cells of SVZ-NSPCs in the organotypic brain. (G and H) Immunohistochemistry and quantification graph of the ratio of Olig2+ 
and BrdU+ cells of SVZ-NSPCs in the organotypic brain (Scale bar=20 um, **p<0.05 vs M0 conditioned media, n=5/group).
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showed that microglia-conditioned media rescue the in vitro 
formation of neuroblasts from NSPCs in SVZ [37]. To determine 
the role of activated microglia in functional neurogenesis, we 
collected M1 and M2 phenotype microglia-conditioned media 
and found that M2 phenotype microglia released TGF-α.
TGF-α is a member of the epidermal growth factor (EGF) 
family that actives the EGF-receptor (EGF-R) trans-membrane 
tyrosine kinase [38, 39]. This mechanism shows that the increase 
in intracellular calcium levels, glycolysis and expression of certain 
genes, such as EGF-R gene, ultimately lead to DNA synthesis and 
cell proliferation [40]. Both TGF-α and EGF-R are located in the 
SVZ where they regulate the activity of neural progenitor cells 
[41]. Previous reports have suggested that TGF-α also significantly 
amplify the proliferative responses of neural stem cells in the 
SVZ [42], but causes minimal migration in response [43]. In the 
ischemic stroke model, intraventricular TGF-α also reduced the 
infarct volumes. These neuroprotective effects are driven by anti-
apoptotic and anti-inflammatory mechanisms [44]. Recently, study 
also showed that macrophage secrete TGF-α and even when the 
tissue was culutred in media including TGF-α from surrounding 
infarct lesion, this protective effect was maintained [42].
In the current study, we found that M2 phenotype microglia 
release TGF-α, whic it may be affect the neurogenesis of NSPCs 
in SVZ. This event was associated with the effect of TGF-α on the 
proliferation and migration of NSPCs. However, in the current 
study, we failed to see any changes of neuron and oligodendrocyte 
of SVZ-NSPCs with or without TGF-α in M2 conditioned media. 
We report for the first time that microglia-derived TGF-α plays a 
role in the proliferation and neurogenesis of NSPCs in the SVZ 
after ischemic stroke and is involved in neurological recovery. We 
also suggest that microglia-derived cytokines should be studied 
further in neurogenesis related brain injury.
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